Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2009-03-25Clinical Trial Update: Pharmacokinetic Study of Vildagliptin in Patients With Renal Impairment [Phase 1]
Phase 1 pharmacokinetic study of vildagliptin in patients with renal impairment completed.
-
FDA approval · 2009-03-23FDA Approved: GLYBURIDE AND METFORMIN HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for a generic Glyburide and Metformin Hydrochloride product from Aurobindo Pharma Limited.
-
CLINICAL_TRIALS trial_result · 2009-03-18Clinical Trial Update: 24-Hour Glycemia: Rosiglitazone Versus Glimepiride In Type 2 Diabetes [Phase 4]
Phase 4 randomized trial comparing rosiglitazone with glimepiride in type 2 diabetes, assessing 24-hour glycemic control. The results were p…
-
CLINICAL_TRIALS trial_result · 2009-03-18Clinical Trial Update: Glucagon-Like Peptide-1 (GLP-1) Suppression of Alpha Cell Secretion in Type 2 Diabetes Mellitus (T2DM) [NA]
A completed clinical trial evaluating whether glucagon-like peptide-1 (GLP-1) suppresses alpha cell secretion in type 2 diabetes mellitus.
-
FDA approval · 2009-03-16FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for insulin lispro from Eli Lilly and Company. The approval updates the product's labeling and/o…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2009-03-16FDA Approved: HUMALOG MIX50/50 KWIKPEN — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for HUMALOG MIX50/50 KWIKPEN (insulin lispro) from Eli Lilly and Company. The action updates the pro…
-
CLINICAL_TRIALS trial_result · 2009-03-16Clinical Trial Update: Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of BMS-686117 in Subjects With Type 2 Diabetes [Phase 1]
A Phase 1 study evaluating the safety, pharmacokinetics, and pharmacodynamics of BMS-686117 in subjects with Type 2 diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2009-03-12Clinical Trial Update: Medical Nutrition Therapy Program for Pregnant Women With Diabetes [NA]
Clinical trial update on a medical nutrition therapy program for pregnant women with diabetes; the study status is completed.
-
FDA approval · 2009-03-11FDA Approved: GLIPIZIDE — Supplemental Application (ANI Pharmaceuticals, Inc.)
FDA approved a supplemental application for Glipizide by ANI Pharmaceuticals, approving a generic version of the diabetes medication. It is …
-
CLINICAL_TRIALS trial_result · 2009-03-10Clinical Trial Update: Efficacy of GLP-1 Infusion in Comparison to an Insulin Infusion Protocol to Reach Normoglycemia Type 2 Diabetic Patients [Phase 4]
Phase 4 clinical trial comparing GLP-1 infusion to an insulin infusion protocol to achieve normoglycemia in adults with Type 2 diabetes has …
-
CLINICAL_TRIALS trial_result · 2009-03-06Clinical Trial Update: A Clinical Trial Comparing The Efficacy And Safety Of 2 Different Initial Dose Prescriptions For Exubera. [Phase 4]
A Phase 4 trial comparing two initial dose prescriptions for Exubera (insulin human inhalation powder) in Type 2 diabetes was terminated, wi…
-
FDA approval · 2009-03-05FDA Approved: GLYBURIDE — Supplemental Application (TEVA Pharmaceuticals USA Inc)
FDA approved a supplemental application for glyburide submitted by TEVA Pharmaceuticals USA Inc.
-
CLINICAL_TRIALS trial_result · 2009-03-02Clinical Trial Update: Placebo Controlled Dose-Response Study of Rivoglitazone in Type 2 Diabetes [Phase 2]
A Phase 2, placebo-controlled dose-response study of rivoglitazone in type 2 diabetes has completed, according to an update from the sponsor…
-
CLINICAL_TRIALS research · 2009-03-02Clinical Trial Update: Exercise Effects on Cardiovascular Risk Factors, Quality of Life, Muscle Function in Type 2 Diabetes and Healthy Persons [NA]
Clinical trial update examining the effects of exercise on cardiovascular risk factors, quality of life, and muscle function in people with …
-
FDA approval · 2009-02-24FDA Approved: APIDRA — Supplemental Application (sanofi-aventis U.S. LLC)
FDA approved a supplemental application for APIDRA (insulin glulisine) from Sanofi U.S. LLC, resulting in an updated label for the product.
-
CLINICAL_TRIALS research · 2009-02-19Clinical Trial Update: Shiga Progression of Diabetes, Nephropathy and Retinopathy [NA]
Clinical trial update focusing on progression of diabetes-related nephropathy and retinopathy in Type 2 diabetes mellitus.
-
CLINICAL_TRIALS trial_result · 2009-02-18Clinical Trial Update: Drug-Drug Interaction Study of Mitiglinide and Gemfibrozil [Phase 1]
A Phase 1 study evaluated the drug-drug interaction between mitiglinide and gemfibrozil in adults with type 2 diabetes; the trial has comple…
-
CLINICAL_TRIALS trial_result · 2009-02-18Clinical Trial Update: The Meal Tray as a Tool and Platform to Change Eating Habits Among Hospitalized Diabetic Patients - An Intervention Study [NA]
This clinical trial update investigates using meal trays as a tool to change eating habits in hospitalized patients with Type 2 diabetes; th…
-
CLINICAL_TRIALS trial_result · 2009-02-13Clinical Trial Update: Prospective Influence of Bedtime Insulin Glargine on Mobilization and Function of Endothelial Progenitor Cells [Phase 4]
A Phase 4 study led by Heidelberg University investigates whether bedtime insulin glargine affects mobilization and function of endothelial …
-
CLINICAL_TRIALS trial_result · 2009-02-10Clinical Trial Update: Safety Study to Evaluate BMS-767778 in Healthy Subjects and Subjects With Type 2 Diabetes Mellitus (T2DM) [Phase 1]
Phase 1 safety study of BMS-767778 in healthy subjects and subjects with Type 2 Diabetes Mellitus was terminated.
-
CLINICAL_TRIALS trial_result · 2009-02-09Clinical Trial Update: Placebo and Active Comparator Controlled Dose Response Study of Rivoglitazone in Type 2 Diabetes [Phase 2]
Phase 2 trial of rivoglitazone in type 2 diabetes completed; the study evaluated placebo and an active comparator to characterize dose–respo…
-
CLINICAL_TRIALS trial_result · 2009-02-09Clinical Trial Update: Dose-Ranging Study Evaluating AVE2268 in Patients With Type 2 Diabetes Not Adequately Controlled by a Metformin Treatment [Phase 2]
Phase 2 dose-ranging trial of AVE2268 in patients with Type 2 Diabetes Mellitus not adequately controlled by metformin has completed.
-
CLINICAL_TRIALS trial_result · 2009-02-05Clinical Trial Update: A Study to Evaluate the Effects of ER Niacin/Laropiprant, Laropiprant, ER Niacin, and Placebo on Urinary Prostanoid Metabolites (0524A-079)(COMPLETED) [Phase 1]
A completed Phase 1 study in type 2 diabetes evaluated the effects of extended-release niacin and laropiprant (alone and in combination) ver…
-
CLINICAL_TRIALS trial_result · 2009-02-05Clinical Trial Update: Study of Weight Loss Using Gastric Stimulation in Obese Patients With Type 2 Diabetes [NA]
A completed clinical trial evaluated gastric stimulation for weight loss in patients with obesity and type 2 diabetes, sponsored by Medtroni…
-
CLINICAL_TRIALS research · 2009-02-04Clinical Trial Update: Randomised Trial of Health Coaching in Secondary Prevention of Diabetes and Heart Disease [Phase 3]
This is a Phase 3 randomized trial evaluating health coaching for secondary prevention of Type 2 diabetes mellitus and heart disease. The cu…